Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATBPF | BMY | AMGN | GILD | REGN |
| Company | Antibe Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2328 | 47.93 | 265.64 | 67.01 | 901.26 |
| High | 0.2452 | 48.40 | 265.92 | 67.02 | 908.81 |
| Low | 0.1889 | 47.62 | 262.58 | 65.90 | 891.67 |
| Last | 0.2156 | 48.30 | 262.75 | 66.16 | 893.99 |
| Change | +0.0256 | +0.46 | -1.32 | -0.77 | -7.20 |
| % Change | +13.47% | +0.96% | -0.50% | -1.15% | -0.80% |
| Volume | 33,900 | 10,917,500 | 2,082,700 | 6,442,200 | 450,600 |
| 20-Day Average Volume | 41,625 | 11,419,555 | 2,201,900 | 6,214,910 | 434,065 |
| Previous Close | 0.1900 | 47.84 | 264.07 | 66.93 | 901.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2805 | 50.99 | 272.96 | 70.21 | 938.74 |
| 20-Day Raw Stochastic | 40.74% | 9.99% | 0.65% | 3.10% | 4.01% |
| 20-Day Relative Strength | 34.47% | 37.48% | 36.64% | 27.91% | 33.38% |
| Weighted Alpha | +1.76 | -30.16 | +4.25 | -25.27 | +11.94 |
| Today's Opinion | 56% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 56% Sell | 56% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 8% Sell | 24% Sell | 8% Sell | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +86.99% since 04/01/24 | -1.67% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -2.86% since 04/11/24 |
| Low | 0.1113 on 04/02/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.2452 on 04/08/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -36.00% since 03/08/24 | -6.38% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -6.87% since 03/18/24 |
| Low | 0.1113 on 04/02/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.3582 on 03/13/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -74.24% since 01/08/24 | -3.57% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | -3.87% since 01/18/24 |
| Low | 0.1113 on 04/02/24 | 47.58 on 02/06/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.8122 on 01/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -35.64% since 10/04/23 | -15.04% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | +8.23% since 10/18/23 |
| Low | 0.1113 on 04/02/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 0.8855 on 11/09/23 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,423 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 52,981 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -14,730,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -3,090,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.51 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/14/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 02/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |